Explorer les evidences

53,12 %L'extrait de dichlorométhane d'écorce de tige de D. cinerea a un taux de suppression des parasites de 53,12 % chez des souris infectées par Plasmodium berghei.

NigeriapaludismeHAL · Unilimdocument de 173 observations

6 %Type 2 diabetes mellitus accounted for 6.0% of the prominent causes of morbidity.

Nigeriadiabète de type 2publié 2024Ghana medical journalPubMeddocument de 9 observations

2,39 odds_ratioWomen who inject or use illegal drugs had 2.39 higher odds of facing limited access to sexual and reproductive health services when needed during the COVID-19 pandemic in Nigeria.

Nigeriasexual and reproductive healthobservé 2021publié 2022African journal of AIDS research : AJARPubMeddocument de 4 observations

1,74 aORPrevious low-level viremia was associated with an adjusted odds ratio of 1.74 (95% CI: 1.56–1.93) for subsequent virologic nonsuppression among people with HIV on tenofovir, lamivudine, and dolutegravir (TLD).

NigeriaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 8 observations

4,44 rate_ratioIn Nigeria, remote consultations increased four-fold with a rate ratio of 4.44 (95% CI 1.34 to >10; p=0.01).

Nigeriamaladies non transmissiblespublié 2023The Lancet. Global healthPubMeddocument de 10 observations

87 %Virologic suppression using a cut-off of less than 50 copies/ml was 87% among persons with HIV who initiated ART between January 2016 and September 2022 in Nigeria.

NigeriaVIH/sidapublié 2023AIDS (London, England)PubMeddocument de 4 observations

32,1 %HPV-16 seroprevalence among women aged 35–39 years in Central Nigeria was 32.1%.

Nigeriainfection à HPVobservé August 2016 to January 2018publié 2021The Pan African medical journalPubMeddocument de 17 observations

42,9 %Tooth wear lesions were reported in 42.9% of cases.

Nigeriatooth wear lesionspublié 2026BMC oral healthPubMeddocument de 10 observations

85,7 %The prevalence of Epstein-Barr virus (EBV) infection among patients with nasopharyngeal malignancy in Nigeria was 85.7%.

NigeriaEpstein-Barr virus (EBV) infectionpublié 2022Indian journal of medical microbiologyPubMeddocument de 8 observations

Significant clusters of HIV infection among people who inject drugs (PWID) in Nigeria were confined to the North Central and South South regions.

NigeriaVIH/sidaobservé October 1, 2016 to September 30, 2017publié 2021JMIR public health and surveillancePubMeddocument de 6 observations

20,7 %20.7% of HIV-positive male partners had disclosed their HIV status to all partners.

NigeriaVIH/sidapublié 2020Current HIV researchPubMeddocument de 5 observations

19 participantsNineteen out of 46 participants (41%) could not name risk factors for breast cancer.

Nigeriacancer du seinpublié 2025BMC cancerPubMeddocument de 11 observations

7,7 %Among 143 children with malaria, 11 (7.7%) had anemia.

Nigeriapaludismepublié 2024Journal of vector borne diseasesPubMeddocument de 6 observations

1 %Among 490 analysed alleles from 245 homozygous sickle cell disease patients in Nigeria, five (1.0%) had the Bantu/Central African Republic haplotype.

Nigeriadrépanocytosepublié 2021The Journal of international medical researchPubMeddocument de 5 observations

39 %39% of the ART clients investigated were aged 25–34 at their last ART pick-up date, and 32% of those aged 25–34 had interrupted treatment.

NigeriaVIH/sidaobservé 2000-2020publié 2021BMC public healthPubMeddocument de 12 observations

22,4 %Pack cell volume (PCV) in steady state subjects was 22.4 ± 2.7.

Nigeriadrépanocytosepublié 2022The Pan African medical journalPubMeddocument de 14 observations

1 %The public health department had the least proportion of sickle cell disease cases at 1%.

Nigeriadrépanocytoseobservé 2013 to 2014publié 2022The Pan African medical journalPubMeddocument de 9 observations

HPV vaccination uptake remains low in Nigeria.

Nigeriainfection à HPVpublié 2025Journal of health, population, and nutritionPubMeddocument de 5 observations

0,02 aORPaediatrics on salvage antiretroviral regimen had an adjusted odds ratio of 0.02 for interruption of antiretroviral therapy.

NigeriaVIH/sidapublié 2021BMC public healthPubMeddocument de 12 observations

29,7 %Lassa fever has an estimated fatality rate of 29.7%.

Nigeriafièvre de Lassapublié 2024Nature microbiologyeurope_pmcdocument de 2 observations

5 %In the moderate-dose hydroxyurea group, five (5%) of 111 participants had strokes, with an incidence rate of 1.92 per 100 person-years.

NigeriaAVCpublié 2022The Lancet. HaematologyPubMeddocument de 6 observations

53,7 %The study included 65 (53.7%) females and 56 (46.3%) males among HIV-infected children on HAART.

NigeriaVIH/sidapublié 2025African health sciencesPubMeddocument de 7 observations

94 ng/mlThe baseline median inhibitory concentration of chloroquine against Plasmodium falciparum clone W2 was about 94 ng/ml.

Nigeriapaludismepublié 2006Annals of tropical medicine and parasitologyeurope_pmcdocument de 2 observations

57,6 %Overall, only 57.6% of respondents possessed a comprehensive knowledge of HIV.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 7 observations

0,44 odds_ratioAmong HIV-positive individuals, the TGF-β1 rs1800470 polymorphism (GG vs AA) was associated with a reduced risk of prevalent chronic kidney disease, with an adjusted odds ratio of 0.44.

Nigeriamaladie rénale chronique · VIH/sidapublié 2020American journal of kidney diseases : the official journal of the National Kidney FoundatiPubMeddocument de 7 observations